SEARCH

SEARCH BY CITATION

References

  • 1
    Baughman RP,Lower EE,du Bois RM. Sarcoidosis. Lancet 2003; 361: 11118.
  • 2
    Bresnitz EA,Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983; 5: 12456.
  • 3
    Rybicki BA,Major M,Popovich J,Jr,Maliarik MJ,Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 23441.
  • 4
    Baughman RP,Teirstein AS,Judson MA,Rossman MD,Yeager H,Jr,Bresnitz EA,DePalo L,Hunninghake G,Iannuzzi MC,Johns CJ,McLennan G,Moller DR, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 17545.
  • 5
    Brincker H,Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 1974; 29: 24751.
  • 6
    Yamaguchi M,Odaka M,Hosoda Y,Iwai K,Tachibana T. Excess death of lung cancer among sarcoidosis patients. Sarcoidosis 1991; 8: 515.
  • 7
    Seersholm N,Vestbo J,Viskum K. Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997; 52: 8924.
  • 8
    Rømer FK,Hommelgaard P,Schou G. Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J 1998; 12: 90612.
  • 9
    Askling J,Grunewald J,Eklund A,Hillerdal G,Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999; 160: 166872.
  • 10
    Smedby KE,Hjalgrim H,Askling J,Chang ET,Gregersen H,Porwit-MacDonald A,Sundström C,Akerman M,Melbye M,Glimelius B,Adami HO. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98: 5160.
  • 11
    World Health Organization. International classification of diseases, 8th ed. Geneva: WHO, 1967.
  • 12
    World Health Organization. International classification of diseases, 9th ed. Geneva: WHO, 1977.
  • 13
    Sohn MW,Arnold N,Maynard C,Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Population Health Metrics 2006; 4: 2.
  • 14
    Breslow NE,Day NE. Statistical methods in cancer research, vol. 2. The design and analysis of cohort studies. Lyon: IARC, 1987. 1406.
  • 15
    Berliner AR,Haas M,Choi MJ. Sarcoidosis: the nephrologist's perspective. Am J Kidney Dis 2006; 48: 85670.
  • 16
    Hartge P,Wang S,Bracci MP,Devesa SS,Holly EA. Non-Hodgkin lymphoma. In: Schottenfeld D,Fraumeni JF, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 2006. 898918.
  • 17
    Harf RA,Ethevenaux C,Gleize J,Perrin-Fayolle M,Guerin JC,Ollagnier C. Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann NY Acad Sci 1986; 465: 62531.
  • 18
    Douglas JG,Middleton WG,Gaddie J,Petrie GR,Choo-Kang YF,Prescott RJ,Crompton GK. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986; 41: 78791.
  • 19
    Rabin DL,Richardson MS,Stein SR,Yeager H,Jr. Sarcoidosis severity and socioeconomic status. Eur Respir J 2001; 18: 499506.
  • 20
    Tobi M,Kobrin I,Ariel I. Rectal involvement in sarcoidosis. Dis Colon Rectum 1982; 25: 4913.